Can a simple device improve dialysis? small study tests HemoCept

NCT ID NCT07217470

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed pilot study tested whether the HemoCept device can accurately measure fluid removal during dialysis in 26 adults with end-stage kidney disease. Researchers compared device readings before and after dialysis to changes in dry weight. The goal is to see if this non-invasive tool could help doctors better manage fluid balance during treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HemoCept device

What this could lead to

If successful, this could lead to a non-invasive way to monitor fluid removal during dialysis, improving treatment precision.

What could go wrong

This is a small pilot study with only 26 participants, so results may not apply to everyone. The device is still experimental and may not prove accurate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESRD (END STAGE RENAL DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sierra Nevad Specialty Care

    Reno, Nevada, 89511, United States